The financials look pretty sick.
In fact, if you took out the share based payment to employees in 2017, the 2018 loss is actually worst than 2017 year.
The existing product range is just not selling.
Can't hide that anymore.
Now the company is putting all its hope on Uganic products - certainly hope they have done enough market research, as they have mortgaged the whole company on the success of Uganic.
Good luck to holders, I will continue to sit on the fence on this one.
Ann: Appendix 4D & Half Year Report, page-2
Add WNX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.0¢ |
Change
0.005(0.72%) |
Mkt cap ! $19.62M | |||
| Open | High | Low | Value | Volume |
| 70.5¢ | 70.5¢ | 69.0¢ | $9.524K | 13.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 64.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.5¢ | 4511 | 1 |
View Market Depth
| Last trade - 14.51pm 11/11/2024 (20 minute delay) ? |
| WNX (ASX) Chart |